ATE232388T1 - Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs - Google Patents

Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs

Info

Publication number
ATE232388T1
ATE232388T1 AT98955783T AT98955783T ATE232388T1 AT E232388 T1 ATE232388 T1 AT E232388T1 AT 98955783 T AT98955783 T AT 98955783T AT 98955783 T AT98955783 T AT 98955783T AT E232388 T1 ATE232388 T1 AT E232388T1
Authority
AT
Austria
Prior art keywords
treatment
middle ear
production
active agent
medicinal product
Prior art date
Application number
AT98955783T
Other languages
English (en)
Inventor
Brian Andrew Hills
Derek Alan Woodcock
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9727275.1A external-priority patent/GB9727275D0/en
Priority claimed from GBGB9801328.7A external-priority patent/GB9801328D0/en
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE232388T1 publication Critical patent/ATE232388T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98955783T 1997-12-24 1998-11-26 Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs ATE232388T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9727275.1A GB9727275D0 (en) 1997-12-24 1997-12-24 Medicaments for treatment of disorders of the middle ear
GBGB9801328.7A GB9801328D0 (en) 1998-01-21 1998-01-21 Medicaments for treatment of disorders of the middle ear
PCT/GB1998/003526 WO1999033472A1 (en) 1997-12-24 1998-11-26 Use of surface active agent for the manufacture of a medicament for treatment of disorders of the middle ear

Publications (1)

Publication Number Publication Date
ATE232388T1 true ATE232388T1 (de) 2003-02-15

Family

ID=26312846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98955783T ATE232388T1 (de) 1997-12-24 1998-11-26 Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs

Country Status (8)

Country Link
US (1) US6395295B1 (de)
EP (1) EP1054679B1 (de)
AT (1) ATE232388T1 (de)
AU (1) AU1250999A (de)
DE (1) DE69811407T2 (de)
DK (1) DK1054679T3 (de)
ES (1) ES2191355T3 (de)
WO (1) WO1999033472A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
GB0312007D0 (en) * 2003-05-24 2003-07-02 Innovata Biomed Ltd Container
WO2005030226A1 (en) * 2003-09-25 2005-04-07 Lamellar Therapeutics Limited Compositions and methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US7833282B2 (en) 2006-02-27 2010-11-16 Mandpe Aditi H Eustachian tube device and method
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
WO2009152374A2 (en) 2008-06-12 2009-12-17 Medtronic Xomed, Inc. Method for treating chronic wounds
EP2346324A4 (de) 2008-10-06 2012-10-10 Microbial Defense Systems Llc Antimikrobielle zusammensetzung sowie verfahren zu ihrer herstellung und verwendung
EP3456200B1 (de) 2011-05-10 2023-05-03 Next Science IP Holdings Pty Ltd Artikel mit einem antimikrobiellen feststoff und dessen verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
WO1991017766A1 (fr) * 1990-05-18 1991-11-28 Tokyo Tanabe Company Limited Remede contre l'asthme
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
WO1997029738A1 (en) 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation

Also Published As

Publication number Publication date
US6395295B1 (en) 2002-05-28
DK1054679T3 (da) 2003-03-31
WO1999033472A1 (en) 1999-07-08
DE69811407D1 (de) 2003-03-20
EP1054679B1 (de) 2003-02-12
AU1250999A (en) 1999-07-19
DE69811407T2 (de) 2003-11-20
ES2191355T3 (es) 2003-09-01
EP1054679A1 (de) 2000-11-29

Similar Documents

Publication Publication Date Title
DE69811407D1 (de) Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs
NL300209I2 (nl) Benzonaftaleenderivaten, werkwijze voor de bereiding ervan en hun toepassing op farmaceutisch en cosmetisch gebied.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
EG20001A (en) Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DE69716255D1 (de) Verfahren zur behandlung von mittelohrentzündung mittels uridintriphosphaten und verwandten mitteln
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
DE68929563D1 (de) Prostaglandin-Derivate zur Behandlung von Glaukom und ocularer Hypertension
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
DE69401577D1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
DE69515038D1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
ATE229799T1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur behandlung von asthma
AU6894800A (en) Caspase inhibitors and uses thereof
BG106155A (en) Novel derivatives and analogues of galanthamin
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
DE60221283D1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
DE69518840D1 (en) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
SE8703066L (sv) Antiseptisk komposition innehallande etylalkohol och monolaurin
DE69821655D1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
ATE252897T1 (de) Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen
ATE338558T1 (de) Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1054679

Country of ref document: EP

REN Ceased due to non-payment of the annual fee